Eric Singhi: NEW phase 3 study activated at MD Anderson Cancer Center for patients with limited-stage small cell lung cancer

Eric Singhi: NEW phase 3 study activated at MD Anderson Cancer Center for patients with limited-stage small cell lung cancer

Eric Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, recently posted on X:

“NEW phase 3 study activated at MD Anderson Cancer Center for patients with limited-stage small cell lung cancer.
on
Site PIs: Jianjun Zhang and Zhongxing Liao.

Details below.”

Eric Singhi: NEW phase 3 study activated at MD Anderson Cancer Center for patients with limited-stage small cell lung cancer

Eric Singhi: NEW phase 3 study activated at MD Anderson Cancer Center for patients with limited-stage small cell lung cancer

Source: Eric Singhi/X